Skip to content

Trial of colorectal cancer screening in a Thai population

Colorectal cancer screening using immunochemical fecal occult blood testing(iFOBT) in a Thai population aged 45-74 years: a population-based randomized controlled trial

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160410001
Enrollment
20000
Registered
2016-04-10
Start date
2016-05-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer Adenomatous polyps and malignant neoplasias of colon and/or rectum colorectal cancer&#44

Interventions

Experimental Procedure/Surgery,No Intervention No treatment
iFOBT screening,no screening control
See detailed description,See detailed description

Sponsors

Faculty of Public Health, Khon Kaen University, Thailand
Lead Sponsor
College of Public Health&#44
Collaborator
National Taiwan University&#44
Collaborator
Taiwan
Collaborator

Eligibility

Sex/Gender
All
Age
45 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. aged 45 – 74 years 2. living in Nam Phong District, Khon Kaen Province 3. willing to participate in the project

Exclusion criteria

Exclusion criteria: 1. attendance for cancer screening during the last two years 2. having been examined and diagnosed with cancer during the last two years 3. having been examined and diagnosed with inflammatory bowel disease or acute gastritis or a related condition during the last two years

Design outcomes

Primary

MeasureTime frame
Colorectal cancer mortality rates end of study Death registry of the Thai national statistics database

Secondary

MeasureTime frame
adenomatous polyps or malignant neoplasia in colon/rectum end of study colonoscopy and histology

Countries

Thailand

Contacts

Public ContactSupannee Promthet

Khon Kaen University

supannee@kku.ac.th+66 43347057

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026